Addus HomeCare Corporation (ADUS) – What Are Researchers Saying About This Stock?

Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $134.70.

A number of research analysts recently weighed in on the stock. Barclays increased their price objective on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research report on Wednesday, November 4th. Citigroup downgraded shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. UBS Group increased their price target on Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Finally, Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th.

Read Our Latest Analysis on ADUS

Key Addus HomeCare News

Here’s some of the latest news about ADUS:

  • Positive Sentiment: TD Cowen raised its price target to $145 and reiterated a Buy rating; Wall Street Zen also upgraded the stock to Strong Buy. The company’s latest reported quarterly EPS of $1.83 topped the $1.79 consensus, while revenue grew 7% year over year, though it narrowly missed estimates.
  • Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
  • Neutral Sentiment: A report claims short interest was zero shares, despite describing it as a large increase. The conflicting wording makes the short-interest update difficult to interpret.

Insider Buying and Selling

In other Addus HomeCare news, EVP Cliff Donald Blessing sold 2,000 shares of the stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $124.18, for a total value of $248,360.00. Following the transaction, the executive vice president owned 10,183 shares of the company’s stock, valued at approximately $1,264,524.94. This represents a 16.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP David W. Tucker sold 14,850 shares of the firm’s stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $124.75, for a total value of $1,852,537.50. Following the completion of the transaction, the executive vice president directly owned 8,073 shares in the company, valued at $1,007,106.75. The trade was a 64.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 131,655 shares of company stock valued at $16,275,572 over the last ninety days. 4.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently made changes to their positions in the company. Hantz Financial Services Inc. lifted its stake in shares of Addus HomeCare by 21.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after purchasing an additional 109 shares during the period. Nisa Investment Advisors LLC grew its position in Addus HomeCare by 16.9% during the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after buying an additional 111 shares during the period. Assenagon Asset Management S.A. grew its position in Addus HomeCare by 2.0% during the second quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock valued at $593,000 after buying an additional 114 shares during the period. Janney Montgomery Scott LLC grew its position in Addus HomeCare by 1.1% during the first quarter. Janney Montgomery Scott LLC now owns 12,254 shares of the company’s stock valued at $1,148,000 after buying an additional 132 shares during the period. Finally, Net Worth Advisory Group grew its position in Addus HomeCare by 4.1% during the third quarter. Net Worth Advisory Group now owns 3,419 shares of the company’s stock valued at $382,000 after buying an additional 136 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Down 0.6%

ADUS stock opened at $125.49 on Friday. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $131.59. The business has a fifty day moving average price of $118.19 and a 200-day moving average price of $107.10. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a market capitalization of $2.34 billion, a P/E ratio of 20.91, a P/E/G ratio of 1.66 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The firm had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. During the same period in the prior year, the company posted $1.56 earnings per share. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Equities analysts forecast that Addus HomeCare will post 6.41 earnings per share for the current fiscal year.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Read More

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.